iShares U.S. Medical Devices ETF (IHI) Analysis: Innovation's Edge in Healthcare Hardware
Key Takeaways
- IHI provides targeted exposure to U.S. medical device manufacturers and distributors via the Dow Jones U.S. Select Medical Equipment Index, a passive, market-cap-weighted strategy.
- With 47 holdings and a low expense ratio of 0.38%, the ETF features heavy concentration in top names like ISRG (16.7%) and ABT (15.7%), offering pure healthcare equipment sector allocation at 100%.
- The medical devices sector benefits from structural tailwinds like aging populations and AI integration, though regulatory hurdles and supply chain tariffs pose risks.
- Recent trading sessions reflect sector rotation pressures amid higher interest rates, with the ETF lagging broader healthcare amid valuation resets.
- Forward catalysts include procedural volume growth in robotics and minimally invasive devices from top holdings.
iShares U.S. Medical Devices ETF (IHI) Overview
The iShares U.S. Medical Devices ETF (IHI) seeks to track the Dow Jones U.S. Select Medical Equipment Index, which measures the performance of U.S. equities in the medical equipment subsector. This includes manufacturers and distributors of non-disposable devices such as MRI scanners, pacemakers, prosthetics, and X-ray machines. Launched on May 1, 2006, and issued by BlackRock, IHI is a passive, non-diversified ETF listed on NYSE Arca with an expense ratio of 0.38%.
The fund holds 47 stocks, with the top 10 comprising approximately 75% of assets: ISRG (Intuitive Surgical, 16.7%), ABT (Abbott Laboratories, 15.7%), SYK (Stryker, 10.5%), EW (Edwards Lifesciences, 5.0%), IDXX (IDEXX Laboratories, 4.9%), BDX (Becton Dickinson, 4.9%), MDT (Medtronic, 4.5%), RMD (ResMed, 4.5%), BSX (Boston Scientific, 4.2%), and GEHC (GE HealthCare, 4.0%). Sector allocation is 100% healthcare equipment, emphasizing diversified exposure within this niche. The index undergoes quarterly rebalancing to maintain market-cap weighting with concentration caps for diversification.
Industry and Thematic Landscape
The medical devices industry powers advancements in diagnostics, surgery, and patient monitoring, driven by an aging global population increasing demand for chronic disease management and elective procedures. Structural growth stems from innovations like AI-enabled imaging, robotic-assisted surgery, and remote patient monitoring, with the sector projected to expand amid healthcare workforce shortages and a shift to outpatient care.
Key catalysts include rising adoption of minimally invasive technologies and hospital-at-home models, bolstered by capital flows into high-margin areas like structural heart devices and neuromodulation. Regulatory developments, such as FDA refinements for AI/ML-enabled devices (over 1,000 cleared), support innovation but demand robust clinical evidence. Macro factors like U.S. tariffs on imports heighten supply chain risks, while M&A activity—reaching decade highs in 2025—facilitates portfolio optimization. Risks encompass cybersecurity vulnerabilities in connected devices, pricing pressures from payers, and procedural deferrals during economic uncertainty.
Performance and Positioning Snapshot
In recent market cycles, IHI has faced headwinds from sector rotation favoring value over growth-oriented healthcare, compounded by higher interest rates impacting high-valuation medtech stocks. Over recent months, the ETF has declined amid softer procedural volumes and broader healthcare pressures, underperforming the health category with quarterly drops tied to earnings disappointments in equipment demand. This positioning highlights IHI's sensitivity to macro shifts like rate expectations, yet its concentration in robotics and diagnostics leaders positions it for recovery on renewed innovation cycles and elective procedure rebounds.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening, empowering data-driven decisions across sectors like healthcare. Explore the AI Screener today to uncover potential plays in medical devices and beyond.
2026 Outlook and Key Factors to Monitor
Looking to 2026, the medical devices sector—and IHI by extension—stands to benefit from enduring drivers like demographic aging, which amplifies demand for devices addressing cardiovascular, orthopedic, and diagnostic needs among top holdings. Technological convergence, including AI integration in robotics (e.g., ISRG's da Vinci platforms) and connected care ecosystems, could fuel procedural growth, particularly in ambulatory surgery centers as care shifts outpatient.
Policy shifts, such as FDA AI governance and potential tariff escalations on imports, warrant close watch, alongside earnings cycles for leaders like ABT and SYK, which drive over 40% of IHI's weight. Capital flows may intensify via M&A in high-growth niches like pulsed field ablation and neuromodulation, while margin pressures from restructuring prompt efficiency gains. Competitive dynamics with broader healthcare ETFs highlight IHI's niche appeal, but cybersecurity risks in IoMT (Internet of Medical Things) and reimbursement changes could temper upside. Balanced against these, IHI's low expense ratio and structural purity position it to capture sector tailwinds amid moderating rates and innovation acceleration.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
IHI in -1.57% downward trend, falling for three consecutive days on June 02, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where IHI declined for three days, in of 283 cases, the price declined further within the following month. The odds of a continued downward trend are .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on June 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IHI as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Aroon Indicator for IHI entered a downward trend on May 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IHI's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 54 cases where IHI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for IHI just turned positive on May 18, 2026. Looking at past instances where IHI's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IHI advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Category Health